Mr. Omkar Kumar Kuwar - Neuropharmacology - Best Researcher Award

ISF College of Pharmacy - India

Author Profile

SCOPUS
ORCID
GOOGLE SCHOLAR

Summary

Omkar Kumar Kuwar is a passionate and emerging researcher in the field of pharmacology, currently pursuing his master’s at isf college of pharmacy. with a strong academic background including a bachelor of pharmacy and national cadet corps training, he demonstrates discipline, dedication, and academic excellence. his primary research interests focus on neurodegenerative diseases, neuroinflammation, oxidative stress, and mitochondrial dysfunction. his master’s project investigates the neuroprotective role of baicalein through nrf2 signaling pathways, showcasing his capabilities in preclinical research. he also recognizes the interdisciplinary value of technologies like power electronics, particularly in the context of neuroimaging and diagnostic innovation.

Early academic pursuits

Omkar Kumar Kuwar began his academic journey with a strong foundation in pharmaceutical sciences. his undergraduate studies culminated in a bachelor of pharmacy from mewar university, chittorgarh, where he achieved a cgpa of 7.77. during this time, his commitment extended beyond the classroom into co-curricular engagements, notably serving in the national cadet corps (ncc), Neuropharmacology through which he earned both ncc-b and ncc-c certificates with a grade ‘b’. this period marked the beginning of his deep-rooted interest in biomedical research, especially focused on brain diseases and neurodegenerative disorders.

Professional endeavors

Currently pursuing his master's in pharmacy (pharmacology) at isf college of pharmacy, moga, punjab, omkar is refining his expertise in neuropharmacology and experimental therapeutics. his ongoing work integrates cutting-edge research with practical exposure, equipping him with both the theoretical and applied aspects of neuroscience. his project on neuroprotective effects of baicalein against 3-nitropropionic acid-induced rat models of huntington’s disease, approved under iaec protocol 60/2024, illustrates his command over experimental design and ethical animal research. Neuropharmacology this effort includes exploring signaling pathways like nrf2, which are crucial for therapeutic modulation of oxidative stress and autophagy in neurodegenerative conditions.

Contributions and research focus

Omkar’s contributions lie at the intersection of molecular pharmacology and neurological research. he is particularly focused on the pathophysiological mechanisms underlying neurodegenerative diseases such as huntington's and parkinson’s disease. his work delves deep into the roles of oxidative stress, mitochondrial dysfunction, and neuroinflammation, with an emphasis on exploring neuroprotection and autophagy-related interventions. Neuropharmacology using tools like genetic manipulation and biomarker profiling, his research brings new light to cerebrovascular disease and neuroblastoma pathology. despite his primary domain in pharmacology, omkar acknowledges the growing impact of power electronics in biomedical imaging and neuroimaging technologies, especially in supporting the development of precise, portable diagnostic systems.

Impact and influence

Omkar’s academic and research initiatives have already begun to influence his peers and junior researchers. his analytical mindset, paired with effective communication, contributes to an encouraging research atmosphere. by leveraging digital tools and global identifiers such as his orcid id and linkedin profile, he maintains visibility in professional and scientific circles. his outlook extends to interdisciplinary collaboration, Neuropharmacology including the integration of power electronics with pharmacological device development and simulation-based therapeutic testing. such collaborative potential enhances the translational relevance of his studies.

Academic cites

While omkar is at an early stage of his publication journey, the direction of his master’s project positions him well for academic citations. his study's originality, methodological rigor, and relevance to real-world neurodegenerative models create strong publication potential in indexed pharmacological and neuroscience journals. further, through platforms like researchgate and institutional repositories Neuropharmacology, he intends to share his findings with global audiences, contributing to the growing body of knowledge in neuroprotection and nrf2 pathway signaling.

Legacy and future contributions

Omkar aims to leave behind a legacy defined by innovation, ethical research, and impactful contributions to the fields of neuroscience and pharmacotherapy. his vision includes pursuing a doctorate and engaging in collaborative research that bridges traditional pharmacology with emerging technologies such as power electronics, particularly in the development of smart, Neuropharmacology, bio-sensing diagnostic devices. he remains committed to making a constructive impact in both academic and clinical landscapes by fostering a culture of curiosity, integrity, and interdisciplinary exploration.

Notable Publications

1. Title: Molecular crosstalk between GPCR and receptor tyrosine-protein kinase in neuroblastoma: molecular mechanism and therapeutic implications
   Authors: Maparu, K.; Chatterjee, D.; Kaur, R.; Kalia, N.; Kuwar, O.K.; Attri, M.; Singh, S.
   Journal: Medical Oncology
   Year: 2025
2. Title: Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NFĸB, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis
   Authors: Koleshwar Mahto; Omkar Kumar Kuwar; Aayushi Maloo; Nileshwar Kalia
   Journal: Inflammopharmacology
   Date: July 22, 2025
3. Title: Baicalein-mediated regulation of Nrf2/ARE, NFĸB, and MAPK signaling in Huntington’s disease: a promising strategy against neuroinflammation and neurodegeneration
   Authors: Omkar Kumar Kuwar; Shamsher Singh
   Journal: Inflammopharmacology
   Date: July 5, 2025
4. Title: Anti-inflammatory and antioxidant effects of baicalein: targeting Nrf2, and NFĸB in neurodegenerative disease
   Authors: Omkar Kumar Kuwar; Nileshwar Kalia
   Journal: Inflammopharmacology
   Date: March 2025
5. Title: Neuroinflammation and neurodegeneration in Huntington’s disease: genetic hallmarks, role of metals and organophosphates
   Authors: Omkar Kumar Kunwar; Shamsher Singh
   Journal: Neurogenetics
   Date: January 17, 2025

Conclusion

Omkar stands out as a committed and forward-thinking scholar with a clear vision for his academic and research future. by combining his expertise in pharmacology with an openness to integrating technological advancements such as power electronics, he is well-prepared to contribute meaningfully to the biomedical and healthcare research landscape. his journey so far reflects not only strong scientific potential but also a drive to innovate and collaborate, positioning him as a promising figure in the field of neuroscience and therapeutic development.